Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Kazuo KobayashiMasao ToyodaAtsuhito ToneDaiji KawanamiDaisuke SuzukiDaisuke TsuriyaHideo MachimuraHidetoshi ShimuraHiroshi TakedaHisashi YokomizoKei TakeshitaKeiichi ChinKeizo KanasakiMasaaki MiyauchiMasuo SaburiMiwa MoritaMiwako YomotaMoritsugu KimuraNobuo HatoriShinichi NakajimaShun ItoShunichiro TsukamotoTakashi MurataTakaya MatsushitaTakayuki FurukiTakuya HashimotoTomoya UmezonoYoshimi MutaYuichi TakashiKouichi TamuraPublished in: Diabetes & vascular disease research (2023)
With combination therapy of SGLT2i and GLP1Ra, the preceding drug did not affect the renal outcome.